Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/462
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Methocarbamol (Tablet)
|
| dailymed-instance:dosage |
Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.
|
| dailymed-instance:descripti... |
Methocarbamol is an aromatic glycerol ether and is a close chemical relative to mephenesin carbamate, the oldest and most extensively studied of the drugs in this class. The chemical name for Methocarbamol is 3-(o- Methoxyphenoxy)-1,2-propanediol 1-carbamate. The structural formula is: Each tablet, for oral administration, contains 500 mg or 750 mg of methocarbamol. In addition each tablet contains the following inactive ingredients: Colloidal Silicon Dioxide, Lactose Monohydrate, Magnesium Stearate, Methylcellulose, Microcrystalline Cellulose, Pregelatinized Starch and Sodium Starch Glycolate.
|
| dailymed-instance:clinicalP... |
The mechanism of action of methocarbamol in humans has not been established, but may be due to central nervous system depression. It has no direct action on the contractile mechanism of striated muscle, the motor end plate or the nerve fiber.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
Methocarbamol tablets are contraindicated in patients hypersensitive to any of the ingredients.
|
| dailymed-instance:supply |
Methocarbamol Tablets 500 mg: White, round, scored, compressed tablet imprinted���West-ward 290���. Methocarbamol Tablets 750 mg: White, capsule-shaped, scored, compressed tablet imprinted���West-ward 292���. Store at 20-25��C (68-77��F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Manufactured by:West-ward Pharmaceutical Corp.Eatontown, NJ 07724Rev January 2003
|
| dailymed-instance:genericDr... | |
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:precautio... |
Safety and effectiveness in children below the age of twelve (12) years have not been established. It is not known whether this drug is secreted in human milk. As a general rule, nursing should not be undertaken while a patient is on a drug since many drugs are excreted in human milk. Methocarbamol may cause a color interference in certain screening tests for 5-hydroxyindoleacetic acid (5-HIAA) and vanilmandelic acid (VMA).
|
| dailymed-instance:genericMe... |
Methocarbamol
|
| dailymed-instance:fullName |
Methocarbamol (Tablet)
|
| dailymed-instance:adverseRe... |
Lightheadedness, dizziness, drowsiness, nausea, allergic manifestations such as urticaria, pruritus, rash, conjunctivitis with nasal congestion, blurred vision, headache, fever.
|
| dailymed-instance:warning |
Since methocarbamol tablets may possess a general central nervous system depressant effect, patients receiving methocarbamol tablets should be cautioned about combined effects with alcohol and other CNS depressants. Safe use of methocarbamol has not been established with regard to possible adverse effects upon fetal development. Therefore, methocarbamol tablets should not be used in woman who are, or may become, pregnant and particularly during early pregnancy unless in the judgement of the physician, the potential benefits outweigh the possible hazards.
|
| dailymed-instance:indicatio... |
Methocarbamol tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Methocarbamol
|